🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Cheplapharm Registration GmbH — Licensed Medicines

19 medicines held by Cheplapharm Registration GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 19 products held by Cheplapharm Registration GmbH
MedicineActive substanceLicence holderStatus
Roaccutane 10 mg soft capsules
PA25306/001/001
 Isotretinoin Cheplapharm Registration GmbH Marketed
Roaccutane 20 mg soft capsules
PA25306/001/002
 Isotretinoin Cheplapharm Registration GmbH Marketed
Tarceva 100mg film-coated tablets
EU/1/05/311/002
 Erlotinib hydrochloride Cheplapharm Registration GmbH —
Tarceva 150 mg film-coated tablets
EU/1/05/311/003
 Erlotinib hydrochloride Cheplapharm Registration GmbH —
Tarceva 25 mg film-coated tablets
EU/1/05/311/001
 Erlotinib hydrochloride Cheplapharm Registration GmbH —
Zypadhera 405 mg powder and solvent for prolonged release suspension for injection
EU/1/08/479/003
 Olanzapine pamoate monohydrate Cheplapharm Registration GmbH —
ZYPADHERA 210 mg powder and solvent for prolonged release suspension for injection
EU/1/08/479/001
 Olanzapine pamoate monohydrate Cheplapharm Registration GmbH —
Zypadhera 300 mg powder and solvent for prolonged release suspension for injection
EU/1/08/479/002
 Olanzapine pamoate monohydrate Cheplapharm Registration GmbH —
ZYPREXA 10 mg coated tablets
EU/1/96/022/009
 Olanzapine Cheplapharm Registration GmbH —
ZYPREXA 10 mg powder for solution for injection
EU/1/96/022/016
 Olanzapine Cheplapharm Registration GmbH —
Zyprexa 15 mg coated tablets
EU/1/96/022/012
 Olanzapine Cheplapharm Registration GmbH —
ZYPREXA 2.5 mg coated tablets
EU/1/96/022/002
 Olanzapine Cheplapharm Registration GmbH —
ZYPREXA 20 mg coated tablets
EU/1/96/022/014
 Olanzapine Cheplapharm Registration GmbH —
ZYPREXA 5 mg coated tablets
EU/1/96/022/004
 Olanzapine Cheplapharm Registration GmbH —
ZYPREXA 7.5 mg coated tablets
EU/1/96/022/006
 Olanzapine Cheplapharm Registration GmbH —
Zyprexa Velotab 10 mg Orodispersible tablet
EU/1/99/125/002
 Olanzapine Cheplapharm Registration GmbH —
Zyprexa Velotab 15 mg Orodispersible tablet
EU/1/99/125/003
 Olanzapine Cheplapharm Registration GmbH —
Zyprexa Velotab 20 mg Orodispersible tablet
EU/1/99/125/004
 Olanzapine Cheplapharm Registration GmbH —
Zyprexa Velotab 5 mg Orodispersible tablet
EU/1/99/125/001
 Olanzapine Cheplapharm Registration GmbH —

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.